Impact of Outbreak of COVID-19 on Cardiac Biomarker Diagnostic Kits Market
                     Transparency Market Research (TMR) has published a new report titled, ‘Cardiac Biomarker
Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast,
2019–2027’. According to the report, the global cardiac biomarker diagnostic kits market was
valued at around US$ 2.2 Bn in 2018 and is projected to grow at a CAGR of 5.2% from 2019 to
2027
Overview
 Cardiac biomarkers are also called cardiac markers. In a condition when the heart is
damaged  or  stressed,  cardiac  biomarkers  (endogenous  substances  including  enzymes,
hormones, and proteins) are released into the blood.
 Generally,  cardiac  markers  are  used  to  diagnose  heart  attack  and  acute  coronary
syndrome (ACS) or conditions associated with insufficient blood flow to the heart. These
markers are also utilized in the diagnosis and risk stratification of patients with chest pain.
 Among cardiac biomarker tests, troponin is the biomarker test of choice for detecting
heart damage. The test is performed with a blood sample using a needle to draw blood from
a vein in the hand or arm. Troponin is elevated within a few hours of heart damage and
stays elevated up to two weeks.
 There  are  other  established  biomarkers,  such  as  myoglobin  (test  used  along  with
troponin for early detection of heart attack) and creatinine kinase isoenzymes (also called
cardiac enzyme, which is linked with injury of heart muscle and detection of a second heart
attack anticipated shortly after the first)
Request a PDF Brochure 
- https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=62931
Rise in prevalence of cardiovascular diseases across the world to Drive Market
 Growing prevalence of cardiovascular diseases across the world is the major driver for
the growth of global cardiac biomarker diagnostic kits market.
 For instance, the American Heart Association estimated that 121.5 million adults had
cardiovascular diseases between 2013 and 2016
 Advancements  in  novel  technologies  and  increasing  government  funding  for
cardiovascular disease treatment are some of the major factors responsible for the growth
of global cardiac biomarker diagnostic kits market
 Moreover, early detection to track the heart condition and integration of cardiology & IT
are also some of the major factors fuelling the growth of global cardiac biomarker diagnostic
kits market
Troponin Test Kits Segment to Dominate Market
 Based  on  product,  the  global  cardiac  biomarker  diagnostic  kits  market  has  been
segmented into troponin test kits, CK-MB test kits,  myoglobin test kits,  BNP test kits,  C-
reactive Protein (hsCRP), and other biomarkers
 Troponin  test  kits  segment  is  accounted  for  major  market  share  in  global  cardiac
biomarker diagnostic kits market in 2018
 Growth of troponin test kits segment can be ascribed to its prodigious specificity and
ability to accurately detect the cardiac events of acute coronary syndrome (ACS).
Request a Sample of Cardiac Biomarker Diagnostic Kits Market: 
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=62931
Cardiac Heart Failure – Promising Application Segment
 In terms of application, the global cardiac biomarker diagnostic kits market has been
divided into angina pectoris, myocardial infarction (MI), cardiac heart failure, and others
 Angina pectoris dominated the global market in 2018 and is projected to dominate by
the end of 2027 due to high incidence rate of angina pectoris across the globe
 Cardiac  heart  failure  is  more  lucrative  segment  during  the  forecast  period  which  is
growing with a higher CAGR during the same period of 2019-2027 owing to rise in number
of patient cases for cardiac heart failure across the world
Request for Analysis of COVID19 Impact on Cardiac Biomarker Diagnostic Kits Market - 
https://www.transparencymarketresearch.com/sample/sample.php?
flag=covid19&rep_id=62931
Pont-of-care testing Segment– Higher Growth Rate
 On the basis of testing, the global cardiac biomarker diagnostic kits market has been
bifurcated into laboratory testing, and point-of-care testing
 Point-of-care testing is more promising segment which is expected to grow with higher
CAGR during the forecast period.
 Easy  accessibility  of  point-of-care  testing,  increase  in  preference  for  point-of-care
testing, and new kits & assays being offered by market players for rapid tests are expected
to drive the point-of-care testing segment during the forecast period.
Diagnostic Laboratory End-user Segment- Major Market Share
 Based  on  end-user,  the  global  cardiac  biomarker  diagnostic  kits  market  has  been
segmented into hospitals, clinics, and diagnostic laboratory
 Diagnostic laboratory segment dominated the global cardiac biomarker diagnostic kits
market  in  2018  due  to  rise  in  hospital  admissions  for  dental  procedures,  favorable
reimbursement scenario, and increase in number of advanced diagnostic laboratories in the
last decade which has led to a higher number of diagnostic tests being performed at these
settings
Enquiry before Buying Cardiac Biomarker Diagnostic Kits Market Report - 
https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=62931
North America to Dominate Global Market
 In  terms  of  region,  the  global  cardiac  biomarker  diagnostic  kits  market  has  been
segmented into  North  America,  Europe,  Asia  Pacific,  Latin  America,  and  Middle  East  &
Africa.
 North America accounted for major share of the global cardiac biomarker diagnostic kits
market in 2018 due to higher cardiovascular disease patient population, significant average
selling  price  of  analyzers,  rise  in  demand  for  technologically  advanced  diagnostic
instruments  with  enhanced  specificity  and  precision  among  cardiologist,  and  favorable
coverage as per the Clinical Laboratory Improvement Amendments for in-vitro diagnostic
procedures in the region
 For  instance,  an  article  published  in  the  Medscape  states  that  more  than 9.8
million people  in  the  U.S.  experience  symptoms  of  angina,  annually,  and  more
than 500,000 cases are registered every year
 The cardiac biomarker diagnostic kits market in Asia Pacific is anticipated to expand at a
high CAGR from 2019 to 2027. This can be ascribed to growing aging population, developing
health  care  infrastructure,  large patient  population,  increase in  funding  and investment
toward the development of cardiac analyzers, and surge in focus of both international and
domestic players in the region.
Competitive Landscape
 The global cardiac biomarker diagnostic kits market is consolidated as few players hold
major  market  share  in  global  market.  Key  players  include Abbott  Laboratories,  F.
Hoffmann-La  Roche  Ltd.,  Danaher  Corporation,  Siemens  Healthineers,  bioMérieux  SA,
Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., among
other
More Trending Reports by Transparency Market Research: 
https://www.prnewswire.com/news-releases/technological-advancements-and-innovations-to-
fuel-growth-of-soft-tissue-repair-market-from-2018-to-2026-tmr-301168624.html
https://www.prnewswire.com/news-releases/global-oral-contraceptive-pills-market-projected-
to-expand-at-6-cagr-rising-number-of-unplanned-pregnancies-drives-market-demand-tmr-
301171827.html
https://www.prnewswire.co.uk/news-releases/needle-biopsy-market-to-observe-significant-
growth-avenues-due-to-rising-prevalence-of-cancer-says-tmr-834157631.html
About Us 
Transparency Market Research, a global market research company registered at Wilmington,
Delaware, United States, provides custom research and consulting services. The firm scrutinizes
factors shaping the dynamics of demand in various markets. The insights and perspectives on
the markets evaluate opportunities in various segments.  The opportunities in the segments
based on source, application, demographics, sales channel, and end-use are analysed, which
will determine growth in the markets over the next decade.
 
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking
insights for thousands of decision-makers, made possible by experienced teams of Analysts,
Researchers, and Consultants. The proprietary data sources and various tools & techniques we
use  always  reflect  the  latest  trends  and  information.  With  a  broad  research  and  analysis
capability,  Transparency Market Research employs rigorous primary and secondary research
techniques in all of its business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit 
subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-
TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]